İnovasyon ve fikri mülkiyet · 11.10.20191 dk okuma
Grant of Interim Extension of the Term of U.S. Patent No. 6,406,699-ECI® (ELIAS Cancer Immunotherapy)
Yerel otomatik çeviri · Kaynağın orijinal dili
Özet
The United States Patent and Trademark Office has issued an order granting interim extension for a one-year interim extension of the term of U.S. Patent No. 6,406,699.